• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适用于导航手术的三维酰胺质子转移(APT)成像可呈现与C-蛋氨酸PET相当的胶质母细胞瘤代谢活性。

Three-dimensional amide proton transfer (APT) imaging appliable to navigation surgery can present comparable metabolic activity of glioblastoma to C-Methionine PET.

作者信息

Inoue Akihiro, Watanabe Hideaki, Kusakabe Kosuke, Nishikawa Masahiro, Ohtsuka Sho, Shiraishi Yasuhiro, Taniwaki Mashio, Takimoto Yoshihiro, Matsumoto Masaki, Miyoshi Mitsuharu, Shigekawa Seiji, Kitazawa Riko, Kido Teruhito, Ohnishi Takanori, Takahashi Hisaaki, Kunieda Takeharu

机构信息

Department of Neurosurgery, Ehime University School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.

Division of Neurology, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.

出版信息

Acta Neurochir (Wien). 2025 Feb 19;167(1):49. doi: 10.1007/s00701-025-06465-z.

DOI:10.1007/s00701-025-06465-z
PMID:39969596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11839683/
Abstract

BACKGROUND

Amide proton transfer (APT) imaging has been proposed as a technique to assess tumor metabolic activity. We have previously C-methionine positron emission tomography (C-Met-PET) can evaluate the metabolic activity of peritumoral area including infiltrating tumor cells in glioblastoma (GBM). To resolve disadvantages of C-Met-PET, in the present study, we aimed to evaluate whether three-dimensional fast spin echo-based APT (3D FSE-APT) imaging is usable for not only presenting the metabolic activity of brain tumors, but also detecting areas where infiltrating tumor cells including glioma stem cells (GSCs) could exist, by applying an image-guided navigation system incorporating 3D FSE-APT to glioblastoma surgery.

METHODS

Twenty-six consecutive patients with GBMs were enrolled in this study. Among these 26 cases, 10 patients underwent C-Met-PET examination. All 26 patients underwent two-dimensional single shot fast spine echo-based APT acquisition with a chemical exchange saturation transfer sequence (2D SSFSE-APT). The most recent 14 cases underwent 3D FSE-APT to examine whether 3D APT imaging was applicable to the navigation system. We investigated the clinical applicability of 3D FSE-APT by comparison with 2D SSFSE-APT and evaluated the utility of 3D FSE-APT as a metabolic imaging guide in the intraoperative navigation system. We also analyzed whether 3D FSE-APT can depict the extent of infiltrating tumor cells including GSCs in the peritumoral area in GBM.

RESULTS

The most recent 14 cases underwent 3D FSE-APT. The 3D FSE-APT was visually almost equivalent to 2D SSFSE-APT and mean APT intensity (APT) in GBM obtained by 3D FSE-APT was almost equal to that from 2D SSFSE-APT. Mean APT on 2D SSFSE-APT at the site showing a tumor-to-contralateral normal brain tissue ratio (TNR) of 1.4 on C-Met-PET was 1.52 ± 0.16%. In contrast, mean APT on 3D FSE-APT at the same site was 1.30 ± 0.06%. The optimal cut-off value for APT on 3D FSE-APT was evaluated as 1.28%, offering 100% sensitivity and 100% specificity. Incorporating 3D FSE-APT into the navigation system allowed tumor resection including infiltrating tumor cells under image-guided navigation. Mean Ki-67 staining index in the area with a mean APT of 1.28% was 11.8% (range, 5.0-20.0%).

CONCLUSIONS

The area of tumor invasion could be evaluated by 3D FSE-APT in a similar way to C-Met-PET, and the cut-off value for deciding the borderline between the area including infiltrating tumor cells and that with almost no tumor cells was 12.8%. In addition, 3D FSE-APT could be applied to navigation systems and may have great potential as an imaging modality replacing C-Met-PET in GBM surgery.

摘要

背景

酰胺质子转移(APT)成像已被提议作为一种评估肿瘤代谢活性的技术。我们之前的研究表明,¹¹C-蛋氨酸正电子发射断层扫描(¹¹C-Met-PET)可以评估胶质母细胞瘤(GBM)瘤周区域的代谢活性,包括浸润性肿瘤细胞。为了解决¹¹C-Met-PET的缺点,在本研究中,我们旨在通过将结合了三维快速自旋回波(3D FSE)-APT的图像引导导航系统应用于GBM手术,评估3D FSE-APT成像是否不仅可用于呈现脑肿瘤的代谢活性,还能检测包括胶质瘤干细胞(GSCs)在内的浸润性肿瘤细胞可能存在的区域。

方法

连续纳入26例GBM患者。在这26例患者中,10例患者接受了¹¹C-Met-PET检查。所有26例患者均采用化学交换饱和转移序列进行基于二维单次激发快速自旋回波的APT采集(2D SSFSE-APT)。最近的14例患者接受了3D FSE-APT检查,以研究3D APT成像是否适用于导航系统。我们通过与2D SSFSE-APT比较来研究3D FSE-APT的临床适用性,并评估3D FSE-APT在术中导航系统中作为代谢成像引导的效用。我们还分析了3D FSE-APT是否能描绘GBM瘤周区域包括GSCs在内的浸润性肿瘤细胞的范围。

结果

最近的14例患者接受了3D FSE-APT检查。3D FSE-APT在视觉上与2D SSFSE-APT几乎等效,并且通过3D FSE-APT获得的GBM中的平均APT强度(APT)与2D SSFSE-APT的几乎相等。在¹¹C-Met-PET上肿瘤与对侧正常脑组织比值(TNR)为1.4的部位,2D SSFSE-APT上的平均APT为1.52±0.16%。相比之下,同一部位3D FSE-APT上的平均APT为1.30±0.06%。3D FSE-APT上APT的最佳截断值评估为1.28%,灵敏度和特异性均为100%。将3D FSE-APT纳入导航系统可在图像引导导航下进行包括浸润性肿瘤细胞的肿瘤切除。平均APT为1.28%的区域的平均Ki-67染色指数为11.8%(范围为5.0 - 20.0%)。

结论

3D FSE-APT可以与¹¹C-Met-PET类似的方式评估肿瘤浸润区域,确定包括浸润性肿瘤细胞区域与几乎无肿瘤细胞区域之间边界的截断值为1.28%。此外,3D FSE-APT可应用于导航系统,在GBM手术中作为替代¹¹C-Met-PET的成像方式可能具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/0a8d20af6309/701_2025_6465_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/38b0c2425e1c/701_2025_6465_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/0e504288964c/701_2025_6465_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/f2e9d1358e30/701_2025_6465_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/cb509295b0bc/701_2025_6465_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/3509d3715556/701_2025_6465_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/62c14c5478ce/701_2025_6465_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/0a8d20af6309/701_2025_6465_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/38b0c2425e1c/701_2025_6465_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/0e504288964c/701_2025_6465_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/f2e9d1358e30/701_2025_6465_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/cb509295b0bc/701_2025_6465_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/3509d3715556/701_2025_6465_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/62c14c5478ce/701_2025_6465_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d255/11839683/0a8d20af6309/701_2025_6465_Fig7_HTML.jpg

相似文献

1
Three-dimensional amide proton transfer (APT) imaging appliable to navigation surgery can present comparable metabolic activity of glioblastoma to C-Methionine PET.适用于导航手术的三维酰胺质子转移(APT)成像可呈现与C-蛋氨酸PET相当的胶质母细胞瘤代谢活性。
Acta Neurochir (Wien). 2025 Feb 19;167(1):49. doi: 10.1007/s00701-025-06465-z.
2
Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of C-methionine positron emission tomography.酰胺质子转移成像在最大限度切除恶性脑胶质瘤中的作用:有可能取代 C-蛋氨酸正电子发射断层扫描。
Neurosurg Rev. 2023 Nov 4;46(1):294. doi: 10.1007/s10143-023-02202-1.
3
Met-PET uptake index for total tumor resection: identification of C-methionine uptake index as a goal for total tumor resection including infiltrating tumor cells in glioblastoma.用于总肿瘤切除的 Met-PET 摄取指数:确定 C-蛋氨酸摄取指数作为包括胶质母细胞瘤浸润肿瘤细胞在内的总肿瘤切除的目标。
Neurosurg Rev. 2021 Feb;44(1):587-597. doi: 10.1007/s10143-020-01258-7. Epub 2020 Feb 15.
4
Amide proton transfer imaging of brain tumors using a self-corrected 3D fast spin-echo dixon method: Comparison With separate B correction.使用自校正三维快速自旋回波狄克逊方法对脑肿瘤进行酰胺质子转移成像:与单独的B校正比较。
Magn Reson Med. 2017 Jun;77(6):2272-2279. doi: 10.1002/mrm.26322. Epub 2016 Jul 6.
5
Relationship between multi-pool model-based chemical exchange saturation transfer imaging, intravoxel incoherent motion MRI, and C-methionine uptake on PET/CT in patients with gliomas.基于多池模型的化学交换饱和传递成像、体素内不相干运动 MRI 与 C-蛋氨酸摄取 PET/CT 对脑胶质瘤患者的相关性研究。
Magn Reson Imaging. 2024 Sep;111:148-156. doi: 10.1016/j.mri.2024.05.007. Epub 2024 May 8.
6
A comparison study of dynamic [F]Alfatide II imaging and [C]MET in orthotopic rat models of glioblastoma.立体定向原位脑胶质瘤大鼠模型中动态 [F]Alfatide II 显像与 [C]MET 的对比研究。
J Cancer Res Clin Oncol. 2024 Apr 22;150(4):208. doi: 10.1007/s00432-024-05688-4.
7
A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.使用 11C-蛋氨酸 PET、18F-FDG-PET 和 MRI 融合图像的手术策略治疗无或最小对比增强的胶质瘤。
J Neurooncol. 2018 Jul;138(3):537-548. doi: 10.1007/s11060-018-2821-9. Epub 2018 Mar 7.
8
Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.用于疑似低级别胶质瘤导航引导手术的标准化多模态影像方案介绍。
Neurosurg Focus. 2015 Jan;38(1):E4. doi: 10.3171/2014.10.FOCUS14597.
9
Diagnostic performance between contrast enhancement, proton MR spectroscopy, and amide proton transfer imaging in patients with brain tumors.脑肿瘤患者对比增强、质子磁共振波谱和酰胺质子转移成像的诊断性能。
J Magn Reson Imaging. 2017 Sep;46(3):732-739. doi: 10.1002/jmri.25597. Epub 2017 Mar 2.
10
Evaluation of Brain Tumors Using Amide Proton Transfer Imaging: A Comparison of Normal Amide Proton Transfer Signal With Abnormal Amide Proton Transfer Signal Value.酰胺质子转移成像在脑肿瘤评估中的应用:正常酰胺质子转移信号与异常酰胺质子转移信号值的比较。
J Comput Assist Tomogr. 2023;47(1):121-128. doi: 10.1097/RCT.0000000000001378. Epub 2022 Sep 1.

本文引用的文献

1
Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of C-methionine positron emission tomography.酰胺质子转移成像在最大限度切除恶性脑胶质瘤中的作用:有可能取代 C-蛋氨酸正电子发射断层扫描。
Neurosurg Rev. 2023 Nov 4;46(1):294. doi: 10.1007/s10143-023-02202-1.
2
Grading of gliomas using 3D CEST imaging with compressed sensing and sensitivity encoding.使用基于压缩感知和灵敏度编码的 3D CEST 成像对神经胶质瘤进行分级。
Eur J Radiol. 2023 Jan;158:110654. doi: 10.1016/j.ejrad.2022.110654. Epub 2022 Dec 15.
3
Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsy.
磁共振波谱定量测量肿瘤周围谷氨酸、N-乙酰天冬氨酸和乳酸浓度可预测胶质母细胞瘤相关耐药性癫痫。
Acta Neurochir (Wien). 2022 Dec;164(12):3253-3266. doi: 10.1007/s00701-022-05363-y. Epub 2022 Sep 15.
4
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
5
Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.磁共振波谱定量测量脑胶质母细胞瘤非增强区乳酸对胶质瘤干细胞浸润的预测。
World Neurosurg. 2021 Sep;153:e76-e95. doi: 10.1016/j.wneu.2021.06.044. Epub 2021 Jun 16.
6
A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma.系统评价和荟萃分析显示,对于胶质母细胞瘤而言,次全切除与大体全切除的效果相当。
J Neurooncol. 2020 Jul;148(3):419-431. doi: 10.1007/s11060-020-03556-y. Epub 2020 Jun 19.
7
Met-PET uptake index for total tumor resection: identification of C-methionine uptake index as a goal for total tumor resection including infiltrating tumor cells in glioblastoma.用于总肿瘤切除的 Met-PET 摄取指数:确定 C-蛋氨酸摄取指数作为包括胶质母细胞瘤浸润肿瘤细胞在内的总肿瘤切除的目标。
Neurosurg Rev. 2021 Feb;44(1):587-597. doi: 10.1007/s10143-020-01258-7. Epub 2020 Feb 15.
8
Addition of Amide Proton Transfer Imaging to FDG-PET/CT Improves Diagnostic Accuracy in Glioma Grading: A Preliminary Study Using the Continuous Net Reclassification Analysis.酰胺质子转移成像与 FDG-PET/CT 联合应用提高胶质瘤分级诊断准确性:连续净重新分类分析的初步研究。
AJNR Am J Neuroradiol. 2018 Feb;39(2):265-272. doi: 10.3174/ajnr.A5503. Epub 2018 Jan 4.
9
Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.应用酰胺质子转移加权磁共振成像鉴别恶性胶质瘤的假性进展与真性进展。
J Magn Reson Imaging. 2016 Aug;44(2):456-62. doi: 10.1002/jmri.25159. Epub 2016 Jan 20.
10
Accuracy of diffusion tensor magnetic resonance imaging-based tractography for surgery of gliomas near the pyramidal tract: a significant correlation between subcortical electrical stimulation and postoperative tractography.弥散张量磁共振成像引导的锥体束附近脑胶质瘤手术准确性:皮质下电刺激与术后追踪的显著相关性。
Neurosurgery. 2012 Feb;70(2):283-93; discussion 294. doi: 10.1227/NEU.0b013e31823020e6.